16 Jul 2018

APPLE UPDATES APP ALLOWING PATIENTS TO SEE HEALTH RECORDS ON THEIR IPHONE

  Apple has updated the Health app with the iOS 11.3 beta, debuting a feature for customers to see their medical records right on their iPhone. The updated Health Records section within the Health app brings together hospitals, clinics and the existing Health app to make it easy for consumers

0
16 Jul 2018

STUDY SHOWS RESULTS CHANGING WHITE FAT INTO BROWN FAT FOR EASIER WEIGHT LOSS

Obesity results from excess white fat storage, making it difficult to treat because the effectiveness of diet, exercise, and systemic anti-obesity agents is limited, and in the latter case may cause serious side effects. As a result, researchers are investigating innovative strategies for localized delivery of fat burning compounds via

0
16 Jul 2018

WHY IS IT STILL TAKING SO LONG TO BUILD A STUDY?

  By Nick O’Brien The Tufts Center for the Study of Drug Development released its 2017 eClinical Landscape Study (outsourcing-pharma.com/Article/2017/10/12/Clinical-trial-database-tribulations-stunt-trial-timelines) late last year, and among the results is a troubling statistic. Companies conducting clinical trials are taking an average of 68 days to build their studies, with 77 percent of survey respondents

0
16 Jul 2018

TOP U.K. SURGEON CALLS FOR NEW PROCEDURES TO UNDERGO CLINICAL TRIALS IN ENGLAND

  Prof Derek Alderson, MD and the president of the Royal College of Surgeons, said the benefits of surgical innovations in the United Kingdom must “absolutely, unequivocally” be backed by evidence, either through randomised controlled trials or official registries designed to track patient outcomes. The move would bring surgical innovation

0
16 Jul 2018

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions

0
16 Jul 2018

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

Med-Aesthetic Solutions Inc., the developer and manufacturer of the proprietary SaltFacial skin renewal system, has formed a partnership with Aesthetic Management Partners to represent its product line exclusively, in select markets worldwide. The partnership commenced with a strong presence at The Aesthetic Show in Las Vegas in July. Aesthetic Management

0
08 Jul 2018

GLOBAL CVC MARKET TO GROW AT 3.9%

  The “Global Central Venous Catheters (CVCs) Market 2017-2021” report has been added to Research and Markets’ offering. The CVCs market is expected to grow at a CAGR of 3.94 percent during the period 2017-2021. The report has been prepared based on an in-depth market analysis with inputs from industry

0
26 Jun 2018

DERMAKA HAS NEW ENHANCED NATURAL HEALING FORMULA

  Dermaka cream is an all-natural plant-based product that aids in skin healing, rejuvenation, and substantially reduces redness and bruising. Dermaka cream was developed by Ronald Bush, MD, FACS, to minimize bruising and inflammatory responses of the skin in the post-operative period. While the product has been around for several

0
26 Jun 2018

FLYING HIGH OVER THE SEA OF SAMENESS: WHAT IS THE ROLE OF CONFORMITY IN VEIN TREATMENT?

  By James R. Williams   Healthcare bleeds conformity. And for the most part, for good reason. Physicians are trained to rely on statistically proven techniques to treat a condition. These techniques become the gold standard. Physicians are taught not to deviate from these standards until empirical evidence of another

0
26 Jun 2018

THE MARKETING BOT: HOW TO USE YOUR TIRELESS, HIGH-ROI MARKETING GENIUS

By Scott Harvey It’s been said, and it’s pretty well-accepted, that e-mail is the “killer app” that turned the Internet from an interesting technology into the behemoth it has become. There’s no question that email, and its offspring such as various messaging apps such as Facebook Messenger and WhatsApp, have

0